GAA
Green Alpha Advisors’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.84M | Buy |
58,463
+1,102
| +2% | +$53.6K | 2.72% | 9 |
|
|
2025
Q1 | $1.95M | Buy |
57,361
+32,732
| +133% | +$1.11M | 2.08% | 10 |
|
|
2024
Q4 | $969K | Buy |
24,629
+5,471
| +29% | +$215K | 0.78% | 46 |
|
|
2024
Q3 | $900K | Sell |
19,158
-479
| -2% | -$22.5K | 0.71% | 50 |
|
|
2024
Q2 | $1.06M | Sell |
19,637
-7,319
| -27% | -$395K | 0.85% | 40 |
|
|
2024
Q1 | $1.84M | Buy |
26,956
+2,406
| +10% | +$164K | 1.33% | 21 |
|
|
2023
Q4 | $1.54M | Sell |
24,550
-10,330
| -30% | -$647K | 1.11% | 23 |
|
|
2023
Q3 | $1.58M | Buy |
34,880
+507
| +1% | +$23K | 1.22% | 21 |
|
|
2023
Q2 | $1.93M | Buy |
34,373
+1,790
| +5% | +$100K | 1.27% | 17 |
|
|
2023
Q1 | $1.47M | Buy |
32,583
+1,937
| +6% | +$87.6K | 1.03% | 31 |
|
|
2022
Q4 | $1.25M | Buy |
30,646
+3,180
| +12% | +$129K | 1.04% | 29 |
|
|
2022
Q3 | $1.8M | Sell |
27,466
-200,820
| -88% | -$13.1M | 1.52% | 7 |
|
|
2022
Q2 | $13.9M | Buy |
228,286
+202,753
| +794% | +$12.3M | 3.19% | 6 |
|
|
2022
Q1 | $1.6M | Buy |
25,533
+8,374
| +49% | +$526K | 1.08% | 30 |
|
|
2021
Q4 | $1.3M | Buy |
17,159
+2,237
| +15% | +$169K | 0.88% | 47 |
|
|
2021
Q3 | $1.67M | Buy |
14,922
+2,214
| +17% | +$248K | 1.15% | 24 |
|
|
2021
Q2 | $2.06M | Buy |
12,708
+5,914
| +87% | +$957K | 1.4% | 7 |
|
|
2021
Q1 | $828K | Buy |
6,794
+442
| +7% | +$53.9K | 0.82% | 51 |
|
|
2020
Q4 | $973K | Buy |
+6,352
| New | +$973K | 1.18% | 27 |
|